US Patent Issued to Arvinas Operations on Sept. 30 for "Compounds and methods for the targeted degradation of androgen receptor" (Connecticut Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,144, issued on Sept. 30, was assigned to Arvinas Operations Inc. (New Haven, Conn.).

"Compounds and methods for the targeted degradation of androgen receptor" was invented by Lawrence B. Snyder (Killingworth, Conn.), Andrew P. Crew (Chester, Conn.), Jing Wang (Milford, Conn.) and Hanqing Dong (Madison, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure pertains to compounds, the preparation thereof, and the use of these compounds in the treatment of prostate cancer, including metastatic and/or castrate-resistant prostate cancer, in subjects in need thereof."

The patent was filed on Sept. 1, 2023, under Application No. 18/460,063....